Mechanisms of GPCR Signaling

GPCR 信号传导机制

基本信息

项目摘要

The light-activated visual receptor rhodopsin has provided the foundation for understanding the structure and mechanism of G protein-coupled receptors (GPCRs). Nevertheless, there remain fundamental unanswered questions about how these receptors work. Here, we target several basic questions that are relevant for understanding their mechanism(s) of activation. The approach is primarily through structural measurements using solid-state NMR spectroscopy. The existing crystal structures of these receptors provide a high- resolution framework to study in detail the role of specific residues and motifs in receptor activation. Because of the high conservation of residues between the visual and ligand-activated GPCRs, the emerging consensus is that rather than being unique, the visual receptors provide a basis for understanding the common structural and dynamic elements in these receptors. The general experimental strategy is to use solid-state NMR spectroscopy in combination with mutational, optical and biochemical methods to target specific regions in the inactive and active states of the dim-light receptor, rhodopsin. The goal is to understand in atomic detail the interplay between specific signature, group-conserved and subfamily-conserved motifs in the activation mechanism of rhodopsin and establish a common basis for the activation of other GPCRs. Four specific aims address structure-function questions involving regions on the extracellular side of rhodopsin (Aim 1) and within the transmembrane (TM) core and on the intracellular side of the receptor (Aim 2). In Aim 1, we will establish the role of Trp6.48 – a key residue that mediates retinal isomerization and Schiff base deprotonation with the conserved TM core of the receptor. In Aim 2, we address how retinal Schiff base deprotonation leads to activation. The working model is that there are two triggers, one electrostatic and one steric in nature. We target the conserved TM core of rhodopsin composed of interlocking signature and group- conserved residues. The working model is that the TM core is composed of two packing clusters and two activation switches. These provide stable and flexible elements to the receptor, respectively. In Aim 3, we focus on the G protein and its interactions with residues on the intracellular surface of the active Meta II intermediate. In this aim, we address the role of the membrane environment in receptor stability and activation. Finally, in Aim 4 we use the information garnered above and from past studies to determine the basis for two retinal diseases, congenital stationary night blindness and autosomal dominant retinitis pigmentosa.
光激活的视紫红质受体为理解其结构和功能奠定了基础 G蛋白偶联受体的作用机制。然而,仍然有一些根本问题没有得到回答。 关于这些受体如何工作的问题。在这里,我们针对与以下内容相关的几个基本问题 了解他们的激活机制(S)。这种方法主要通过结构测量来实现。 采用固体核磁共振波谱。这些受体的现有晶体结构提供了高度的- 详细研究特定残基和基序在受体激活中的作用的解析框架。因为 视觉和配体激活的GPCRs之间的残基高度保守,正在形成的共识 视觉感受器不是独一无二的,而是为理解共同的结构提供了基础 以及这些受体中的动态元素。一般的实验策略是使用固态核磁共振 光谱学与突变、光学和生化方法相结合,以靶向 暗光感受器视紫红质的不活跃和活跃状态。目标是在原子细节上理解 特异特征基序、基团保守基序和亚家族保守基序在激活过程中的相互作用 研究视紫红质的作用机制,并为激活其他GPCRs奠定共同基础。 四个具体目标解决涉及视紫红质细胞外侧区域的结构-功能问题 (目标1)以及在跨膜(TM)核心和受体的细胞内侧(目标2)。在目标1中, 我们将确定Trp6.48的作用,Trp6.48是介导视网膜异构化和Schiff碱基的关键残基 与受体保守的TM核心的去质子化。在目标2中,我们讨论了视网膜Schiff碱是如何 去质子化会导致活化。工作模式是有两个触发器,一个是静电,一个是 在自然界中是立体的。我们针对视紫红质保守的TM核心,由连锁签名和基团组成- 保守残基。工作模式是TM核心由两个堆积簇和两个 激活开关。它们分别为受体提供稳定和灵活的元件。在目标3中,我们 关注G蛋白及其与活性Meta II胞内残基的相互作用 中级的。在这个目标中,我们讨论了膜环境在受体稳定和激活中的作用。 最后,在目标4中,我们使用上面和从过去研究中获得的信息来确定两个 视网膜疾病、先天性静止性夜盲和常染色体显性遗传性视网膜色素变性。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

STEVEN Owen SMITH其他文献

STEVEN Owen SMITH的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('STEVEN Owen SMITH', 18)}}的其他基金

Mechanisms of GPCR Signaling
GPCR 信号传导机制
  • 批准号:
    9978838
  • 财政年份:
    2018
  • 资助金额:
    $ 33.15万
  • 项目类别:
Structural Identification and Functional Consequences of Different Amyloid Strains in Alzheimer's Disease
阿尔茨海默病中不同淀粉样蛋白菌株的结构鉴定和功能后果
  • 批准号:
    9672144
  • 财政年份:
    2018
  • 资助金额:
    $ 33.15万
  • 项目类别:
Structural Identification and Functional Consequences of Different Amyloid Strains in Alzheimer's Disease
阿尔茨海默病中不同淀粉样蛋白菌株的结构鉴定和功能后果
  • 批准号:
    10405031
  • 财政年份:
    2018
  • 资助金额:
    $ 33.15万
  • 项目类别:
Structural Identification and Functional Consequences of Different Amyloid Strains in Alzheimer's Disease
阿尔茨海默病中不同淀粉样蛋白菌株的结构鉴定和功能后果
  • 批准号:
    9789805
  • 财政年份:
    2018
  • 资助金额:
    $ 33.15万
  • 项目类别:
Structural Identification and Functional Consequences of Different Amyloid Strains in Alzheimer's Disease
阿尔茨海默病中不同淀粉样蛋白菌株的结构鉴定和功能后果
  • 批准号:
    10176329
  • 财政年份:
    2018
  • 资助金额:
    $ 33.15万
  • 项目类别:
Understanding the Origins of Amyloid Deposition in Cerebral Amyloid Angiopathy
了解脑淀粉样血管病中淀粉样蛋白沉积的起源
  • 批准号:
    9919003
  • 财政年份:
    2017
  • 资助金额:
    $ 33.15万
  • 项目类别:
Understanding the Origins of Amyloid Deposition in Cerebral Amyloid Angiopathy
了解脑淀粉样血管病中淀粉样蛋白沉积的起源
  • 批准号:
    9251922
  • 财政年份:
    2016
  • 资助金额:
    $ 33.15万
  • 项目类别:
500 MHz Solid-State NMR Spectrometer
500 MHz 固态核磁共振波谱仪
  • 批准号:
    7595314
  • 财政年份:
    2009
  • 资助金额:
    $ 33.15万
  • 项目类别:
Mechanism of inhibition of APP processing and amyloid formation
APP 加工和淀粉样蛋白形成的抑制机制
  • 批准号:
    8332308
  • 财政年份:
    2006
  • 资助金额:
    $ 33.15万
  • 项目类别:
Structure-inhibition of amyloid oligomers and fibrils
淀粉样蛋白寡聚体和原纤维的结构抑制
  • 批准号:
    7866473
  • 财政年份:
    2006
  • 资助金额:
    $ 33.15万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 33.15万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 33.15万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.15万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.15万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 33.15万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.15万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 33.15万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 33.15万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 33.15万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.15万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了